Uses of Lirystad 75

Lirystad 75 belongs to the group of psychotropic drugs. Lirystad 75 drug has the main active ingredient Pregabalin, which is used to treat neuropathic pain of central and peripheral origin, adjuvant treatment of partial seizures with or without first generalization in adults.

Lyristad 75 belongs to the group of psychotropic drugs, indicated in the treatment of neuropathic pain, epilepsy, generalized anxiety disorder.
Lyristad 75 is made in the form of 75mg hard capsules, red cap, white capsule body, containing white to ivory white powder. The drug is packaged in a box of 4 blisters x 7 tablets; Box of 2 blisters, 4 blisters x 14 tablets.
Lyristad 75 is composed of the main active ingredient Pregabalin 75mg. Excipients with sufficient content include: Maize starch, lactose monohydrate, talc.

Lyristad 75 is composed of Pregabalin with anticonvulsant and analgesic effects.
Lyristad 75 is indicated in the following cases:
Treatment of central and peripheral neuropathic pain in adults Used as adjunctive therapy in the treatment of partial seizures with or without first generalization in adults. Adults. Used to treat generalized anxiety disorder in adults

3.1. How to use Lyristad 75 Lyristad 75 is only for oral use. Patients can take it with or without food.
3.2. Dosage of Lyristad 75 The dose range of Lyristad 75 is 150 - 600 mg/day divided into 2 or 3 times. Dosage for specific symptoms is as follows:
Pain of nerve origin: Recommended initial dose 150mg/day in 2 or 3 divided doses, may be increased to 300mg/day after 3 to 7 days depending on tolerance and response. Maximum dose 600mg after the next 7 days if needed. Epilepsy: The recommended starting dose is 150 mg/day in 2 or 3 divided doses, and may be increased to 300 mg/day after 1 week depending on tolerability and response. Dosage may be increased to 450mg and to a maximum of 600mg/day at subsequent 1-week intervals. Generalized Anxiety Disorder: The recommended dose is 150 mg to 600 mg/day in 2 or 3 divided doses. Treatment needs should be regularly monitored and re-evaluated. Treatment can be initiated with a pregabalin dose of 150 mg/day and a maximum dose of 600 mg/day. For patients with renal impairment: Dosage reduction in patients with compromised renal function must be individualized according to creatinine clearance. Recommended dosage according to the direction of the treating physician. For the elderly (>65 years old): Reduce dose. Note: The above dosage information is for reference only. In order to have a dose suitable for the condition and the course of the disease, patients need to consult a doctor or pharmacist.
3.3. How to handle when forgetting, overdosing Missed dose:
There are currently no documents on how to handle a missed dose of Lyristad 75. However, if a dose is missed, the patient should take it again as soon as possible. If it is almost time for your next dose, skip the missed dose and take your next dose at the indicated time. Note: Do not double the dose at one time.
Overdose:
When overdosing on Lyristad 75, the most common unwanted side effects include: confusion, agitation and restlessness, drowsiness. Rare cases of coma or seizures.
In case of emergency or overdose with dangerous manifestations, it is necessary to notify the treating physician for general supportive measures and hemodialysis if necessary.
3.4. Lyristad 75 is contraindicated in patients with hypersensitivity to the active ingredient Pregabalin or any of the excipients of the drug.
Contraindicated for children and adolescents under 17 years of age.

Caution when using Lyristad 75 in the following cases: For patients with diabetes: It may be necessary to adjust blood glucose lowering drugs. Lyristad 75 should be used with caution in elderly patients with compromised cardiovascular status (congestive heart failure). Pregnancy: The benefits to the mother should be weighed against the potential risks to the fetus. Lyristad should not be used during pregnancy unless clearly needed. Nursing Mothers: There are no data showing the effects of Pregabalin on the neonate. The decision to use the drug should take into account the benefits of breastfeeding for the infant and the benefits of treatment for the mother. Effects on ability to drive and use machines: Lyristad 75 may have a mild or moderate effect on the ability to do so due to the occurrence of undesirable effects such as: dizziness, somnolence. Patients should not engage in overly complex activities until it is determined that the drug has no effect on their ability to perform these activities. Discontinue use immediately when symptoms of angioedema appear. If pregabalin must be discontinued, avoid abrupt discontinuation. This should be done gradually over a minimum of 1 week. Seizures and major convulsions may occur soon after discontinuation of Pregabalin. Controlling for signs of suicidal ideation and behavior, the patient has a substance abuse condition. Side effects when using Lyristad 75:
When using Lyristad 75, patients may experience unwanted side effects such as:
Very common:
Headache, dizziness, drowsiness. Common:
Nasopharyngitis Increased appetite Excited mood, confusion, insomnia, irritability, disorientation, decreased libido. Abnormal coordination, tremor, dysarthria, balance disorder, attention disorder. Blurred vision, double vision. Dizziness, vomiting, nausea, constipation, diarrhea, dry mouth. Erectile dysfunction; peripheral edema, edema, abnormal gait, fall, feeling intoxicated, unusual sensation, fatigue; weight gain. How to deal with unwanted side effects:
If you encounter any unwanted side effects, it is necessary to inform the treating doctor. Families need to closely monitor the patient.
Drug Interactions Lyristad 75
According to research documents, lower gastrointestinal function has been shown to decrease (eg, constipation, paralytic ileus, intestinal obstruction) when Pregabalin is used concurrently with drugs that cause constipation. as an opioid pain reliever.
Pregabalin may potentiate the effects of ethanol and lorazepam, increasing the decline in cognitive and gross motor function caused by oxycodone.
Storage Lyristad 75
Store medicine in a dry place, the temperature does not exceed 30°C. Avoid exposure to direct sunlight.
Above is all the necessary information and notes when using Lyristad 75. To ensure safety when using the drug, patients need to strictly follow the instructions of the treating doctor.